Genetic Technologies Limited

Genetic Technologies Limitedverified

GENE

Price:

$0.765

Market Cap:

$9.58M

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops othe...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2005-09-06

Stock Exchange

NASDAQ

Ticker

GENE

The ROE as of November 2024 (TTM) for Genetic Technologies Limited (GENE) is -308.47%

According to Genetic Technologies Limited’s latest financial reports and current stock price. The company's current ROE is -308.47%. This represents a change of 180.92% compared to the average of -109.81% of the last 4 quarters.

Genetic Technologies Limited (GENE) Historical ROE (quarterly & annually)

How has GENE ROE performed in the past?

The mean historical ROE of Genetic Technologies Limited over the last ten years is -155.89%. The current -308.47% ROE has changed 97.88% with respect to the historical average. Over the past ten years (40 quarters), GENE's ROE was at its highest in in the June 2011 quarter at 0%. The ROE was at its lowest in in the December 2014 quarter at -1596.75%.

Quarterly (TTM)
Annual

Average

-155.89%

Median

-75.31%

Minimum

-656.53%

Maximum

-32.87%

Genetic Technologies Limited (GENE) ROE by Quarter and Year

Discovering the peaks and valleys of Genetic Technologies Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 523.66%

Maximum Annual ROE = -32.87%

Minimum Annual Increase = -91.61%

Minimum Annual ROE = -656.53%

Quarterly (TTM)
Annual
YearROEChange
2024-656.53%523.66%
2023-105.27%142.56%
2022-43.40%32.04%
2021-32.87%-26.94%
2020-44.99%-87.60%
2019-362.78%212.85%
2018-115.96%45.97%
2017-79.44%11.60%
2016-71.18%53.19%
2015-46.47%-91.61%

Genetic Technologies Limited (GENE) Average ROE

How has GENE ROE performed in the past?

The current ROE of Genetic Technologies Limited (GENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-268.40%

5-year avg

-176.61%

10-year avg

-155.89%

Genetic Technologies Limited (GENE) ROE vs. Peers

How is GENE’s ROE compared to its peers?

Genetic Technologies Limited’s ROE is greater than Biocept, Inc. (-138.49%), less than T2 Biosystems, Inc. (205.97%), greater than HTG Molecular Diagnostics, Inc. (-273.49%), greater than Intelligent Bio Solutions Inc. (-144.39%), greater than Interpace Biosciences, Inc. (-35.22%), greater than bioAffinity Technologies, Inc. (-202.71%), less than SeqLL Inc. (-0.04%), less than Agilent Technologies, Inc. (23.40%), less than Sera Prognostics, Inc. (0%), greater than Precipio, Inc. (-51.73%), greater than MDxHealth SA (-23.41%), greater than null (-1163.85%),

Build a custom stock screener for Genetic Technologies Limited (GENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Technologies Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetic Technologies Limited (GENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetic Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Genetic Technologies Limited's ROE?

How is the ROE calculated for Genetic Technologies Limited (GENE)?

What is the highest ROE for Genetic Technologies Limited (GENE)?

What is the 3-year average ROE for Genetic Technologies Limited (GENE)?

What is the 5-year average ROE for Genetic Technologies Limited (GENE)?

How does the current ROE for Genetic Technologies Limited (GENE) compare to its historical average?